Chemotherapy, radiotherapy and immunotherapy for cancer - MBS item (15338)

The following MBS item is included in this clinical category.

15338
Prostate, radioactive seed implantation of, radiation oncology component, using transrectal ultrasound guidance, for localised prostatic malignancy at clinical stages t1 (clinically inapparent tumour not palpable or visible by imaging) or t2 (tumour confined within prostate), with a gleason score of less than or equal to 7 and a prostate specific antigen (psa) of less than or equal to 10ng/ml at the time of diagnosis. the procedure must be performed at an approved site in association with a urologist.

Return to Chemotherapy, radiotherapy and immunotherapy for cancer item list